There is nothing to explain why that happened to be so.
“75% of APOE e4 carriers in the high Anavex 2-73 concentration cohort”
Still the peer reviewed P2a Subgroup 1 performed best and was differentiated by APOE3 alleles from the other high concentration, S1R wt. and mild AD patients.